DC-SIGN (CD209) Promoter −336 A/G (rs4804803) Polymorphism Associated with Susceptibility of Kawasaki Disease
Kawasaki disease (KD) is characterized by systemic vasculitis of unknown etiology. High-dose intravenous immunoglobulin (IVIG) is the most effective therapy for KD to reduce the prevalence of coronary artery lesion (CAL) formation. Recently, the α2, 6 sialylated IgG was reported to interact with a l...
Main Authors: | Hong-Ren Yu, Wei-Pin Chang, Lin Wang, Ying-Jui Lin, Chi-Di Liang, Kuender D. Yang, Chiu-Ming Kuo, Yi-Chuan Huang, Wei-Chiao Chang, Ho-Chang Kuo |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/2012/634835 |
Similar Items
-
DC-SIGN (CD209) Promoter -336 A/G polymorphism is associated with dengue hemorrhagic fever and correlated to DC-SIGN expression and immune augmentation.
by: Lin Wang, et al.
Published: (2011-01-01) -
Genetic variants of CD209 associated with Kawasaki disease susceptibility.
by: Ho-Chang Kuo, et al.
Published: (2014-01-01) -
Interethnic diversity of the CD209 (rs4804803) gene promoter polymorphism in African but not American sickle cell disease
by: Jenelle A. Noble, et al.
Published: (2015-02-01) -
Different Associations between <i>DC-SIGN</i> Promoter-336G/A (<i>rs4804803</i>) Polymorphism with Severe Dengue in Asians and South-Central Americans: a Meta-Analysis
by: Jiangping Ren, et al.
Published: (2019-04-01) -
Association between CD209 -336A/G and -871A/G polymorphisms and susceptibility of tuberculosis: a meta-analysis.
by: Kai Chang, et al.
Published: (2012-01-01)